{"url":"https://lda.senate.gov/api/v1/filings/bcab3e4a-eca2-4d48-a8dc-91b54dfd5fc3/","filing_uuid":"bcab3e4a-eca2-4d48-a8dc-91b54dfd5fc3","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bcab3e4a-eca2-4d48-a8dc-91b54dfd5fc3/print/","filing_document_content_type":"text/html","income":null,"expenses":"50000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Al Lytton","dt_posted":"2023-01-19T16:07:49-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 Nagog Park","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Acton","registrant_state":"MA","registrant_zip":"01720","registrant":{"id":401106278,"url":"https://lda.senate.gov/api/v1/registrants/401106278/","house_registrant_id":null,"name":"INSULET CORPORATION","description":"Medical device manufacturing, innovative medical technologies","address_1":"100 Nagog Park","address_2":null,"address_3":null,"address_4":null,"city":"Acton","state":"MA","state_display":"Massachusetts","zip":"01720","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AL LYTTON","contact_telephone":"+1 978-932-2867","dt_updated":"2026-07-20T10:12:59.734251-04:00"},"client":{"id":212277,"url":"https://lda.senate.gov/api/v1/clients/212277/","client_id":12,"name":"INSULET CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-10-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the Medical Device industry and the impact of Federal policies Issues related to the care and management of Diabetes and the impact of Federal policies Issues related to telehealth, reimbursement codes and Federal policies following the Public Health Emergency","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":109874,"prefix":null,"prefix_display":null,"first_name":"AL","nickname":null,"middle_name":null,"last_name":"LYTTON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}